EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review

N Fossati, PPM Willemse, T Van den Broeck… - European urology, 2017 - Elsevier
Context There is controversy regarding the therapeutic role of pelvic lymph node dissection
(PLND) in patients undergoing radical prostatectomy for prostate cancer (PCa). Objective To …

Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management

JA Eastham, GB Auffenberg, DA Barocas… - The Journal of …, 2022 - auajournals.org
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Clinically localized prostate cancer: AUA/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up

JA Eastham, GB Auffenberg, DA Barocas… - Journal of …, 2022 - journals.lww.com
Purpose: The summary presented herein represents Part II of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, J Bellmunt, M Bolla, E Briers… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …

Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate-and high-risk prostate cancer: early oncological outcomes from a …

JFP Lestingi, GB Guglielmetti, QD Trinh, RF Coelho… - European urology, 2021 - Elsevier
Background The role of extended pelvic lymph node dissection (EPLND) in the surgical
management of prostate cancer (PCa) patients remains controversial, mainly because of a …

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

C Parker, E Castro, K Fizazi, A Heidenreich… - Annals of …, 2020 - annalsofoncology.org
Subclinical prostate cancer is common in men> 50 years. Population-based screening of
men aged between 55 and 69 years, using prostate-specific antigen (PSA) testing, has been …

[HTML][HTML] The biology and treatment of oligometastatic cancer

DK Reyes, KJ Pienta - Oncotarget, 2015 - ncbi.nlm.nih.gov
Clinical reports of limited and treatable cancer metastases, a disease state that exists in a
transitional zone between localized and widespread systemic disease, were noted on …

Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer

G Gandaglia, N Fossati, E Zaffuto, M Bandini… - European urology, 2017 - Elsevier
Background Preoperative assessment of the risk of lymph node invasion (LNI) is mandatory
to identify prostate cancer (PCa) patients who should receive an extended pelvic lymph …

[HTML][HTML] A DROP-IN gamma probe for robot-assisted radioguided surgery of lymph nodes during radical prostatectomy

P Dell'Oglio, P Meershoek, T Maurer, EMK Wit… - European Urology, 2021 - Elsevier
Abstract Background The DROP-IN gamma probe was introduced to overcome the restricted
manoeuvrability of traditional laparoscopic gamma probes. Through enhanced …